ICD-10 Code C83.17 | Mantle cell lymphoma, spleen Symptoms, Diagnosis, Billing

Mantle cell lymphoma (MCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of B-cells in the mantle zone of lymphoid follicles. When it involves the spleen, it can lead to splenomegaly and systemic symptoms. Accurate coding with ICD-10 Code C83.17 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this aggressive malignancy.

What is ICD-10 Code C83.17 for Mantle cell lymphoma, spleen?

ICD-10 Code C83.17 specifically denotes mantle cell lymphoma localized to the spleen. This code is utilized when documenting cases where the lymphoma has spread to or primarily affects the spleen, which can complicate the clinical picture. It is crucial for accurate clinical documentation and billing, particularly in oncology settings.

ICD-10 Code C83.17 – Clinical Definition and Explanation of Mantle cell lymphoma, spleen

Mantle cell lymphoma, spleen, is a hematological malignancy arising from B-cells, often presenting with advanced disease at diagnosis. It typically progresses rapidly and requires immediate medical intervention due to its aggressive nature. Early recognition and treatment are vital to improve patient outcomes.

Key Clinical Features:

• Splenomegaly (enlarged spleen) often noted on physical examination.
• B-symptoms such as fever, night sweats, and weight loss.
• Cytopenias due to bone marrow infiltration.
• Lymphadenopathy may also be present.

ICD-10 Code C83.17 for Mantle cell lymphoma, spleen – SOAP Notes & Clinical Use

ICD-10 Code C83.17 is integral to SOAP notes, facilitating the documentation of symptoms, assessments, and treatment plans for patients with mantle cell lymphoma affecting the spleen. This code supports both acute and chronic care management, ensuring comprehensive patient records.

What Does ICD-10 Code C83.17 for Mantle cell lymphoma, spleen Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C83.17 connects subjective patient reports and objective clinical findings to a formal diagnosis of mantle cell lymphoma affecting the spleen. This linkage is essential for continuity of care, accurate billing, and compliance with EHR documentation standards.

Treatment Options for ICD-10 Code C83.17 – Mantle cell lymphoma, spleen

Prompt treatment for mantle cell lymphoma affecting the spleen is critical due to its aggressive nature. Hospitalization may be necessary for intensive therapy.

Antibiotic Therapy:

• Not applicable as mantle cell lymphoma is not infectious; however, prophylactic antibiotics may be considered during chemotherapy.
• Consideration for broad-spectrum antibiotics if febrile neutropenia occurs.

Supportive Care:

• Management of symptoms such as pain and splenomegaly.
• Blood transfusions for anemia or thrombocytopenia.
• Nutritional support and counseling.

Infection Control:

• Strict hand hygiene and isolation precautions during chemotherapy.
• Monitoring for signs of infection due to immunosuppression.

How to Document Symptoms of Mantle cell lymphoma, spleen (ICD-10 C83.17) in SOAP Notes

Subjective:

• Patient reports fatigue and unintentional weight loss over the past month.
• Complaints of abdominal discomfort and early satiety.
• History of night sweats and intermittent fever.
• No prior history of lymphoma or significant medical issues.

Objective:

• Physical examination reveals splenomegaly.
• CBC shows anemia and thrombocytopenia.
• Lymph node examination indicates mild cervical lymphadenopathy.
• Imaging studies confirm splenic involvement.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Mantle cell lymphoma, spleen (ICD-10 Code C83.17)

Assessment:

• Diagnosis: Mantle cell lymphoma, spleen, confirmed by biopsy.
• Severity: Advanced stage due to splenic involvement.
• Contributing factors: Possible genetic predisposition and environmental exposures.

Plan:

• Initiate chemotherapy regimen (e.g., R-CHOP or similar protocol).
• Educate patient on potential side effects and the importance of follow-up.
• Schedule regular monitoring of blood counts and response to therapy.
• Plan for follow-up imaging to assess treatment response.

Treatment & Plan Section for ICD-10 Code C83.17 – Mantle cell lymphoma, spleen

• First-line pharmacologic treatments include chemotherapy regimens such as R-CHOP.
• Non-pharmacologic strategies include nutritional support and psychosocial counseling.
• Monitoring practices involve regular CBC checks and imaging studies to assess treatment response.
• Follow-up appointments should be scheduled every 1-3 months during active treatment.

Using ICD-10 Code C83.17 for Mantle cell lymphoma, spleen in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Only list CPT codes that are commonly billed with ICD-10 Code C83.17 based on standard medical coding practices.

Related ICD-10 Codes Often Used with Mantle cell lymphoma, spleen

• C83.10 – Mantle cell lymphoma, unspecified site
• C83.11 – Mantle cell lymphoma, lymph nodes of head, face, and neck
• C83.12 – Mantle cell lymphoma, lymph nodes of axilla and upper limb
• C83.13 – Mantle cell lymphoma, lymph nodes of thorax
• C83.14 – Mantle cell lymphoma, lymph nodes of abdomen

ICD-10 Code C83.17 in Medical Billing and Insurance for Mantle cell lymphoma, spleen

ICD-10 Code C83.17 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure documentation includes detailed patient history and clinical findings.
• Use this code in conjunction with appropriate CPT codes for treatment services.
• Highlight any complications or comorbidities in the documentation to support claims.
• Maintain clear records of treatment plans and patient responses.

Common CPT Pairings: